NCT07045623Recruiting
Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
Source: ClinicalTrials.gov · Last updated 1 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 348 (estimated)
- First submitted
- 24 Mar 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Saint Vincent's Hospital, Korea
- Diseases
- High blood pressure
- NCT number
- NCT07045623
What you commit to
- Study type: Interventional
- Planned participants: 348
- From 1 Apr 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with liver cirrhosis or severe liver disease
- Patients with a history of acute coronary syndrome within the past 6 months
- Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation
Lab values
- Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²)
Who the study is looking for
- Patients registered in the Hanam City Hypertension and Diabetes Program
- Adults aged 30 to 80 years
- Individuals who have provided written informed consent to participate in the study
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Catholic University of Korea, ST. Vincent's Hospital. Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.